论文信息 - HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel - 字舞流文

HER-2/neu as a Predictive Marker in a Population of Advanced Breast Cancer Patients Randomly Treated Either with Single-agent Doxorubicin or Single-agent Docetaxel

D. Larsimont | M. Piccart | K. Friedrichs | J. Isola | M. Aapro | S. Chan | T. Pintér | M. Paesmans | G. von Minckwitz | A. Leo | V. Durbecq | I. Bodrogi | V. Cocquyt | A. Di Leo | G. Minckwitz | P. Simmonds | E. Walpole | E. Murray | B. Lespérance | J. Crown | J. Leroy | S. Korec | Stephen E Chan